Nlight CFO Joseph Corso sells $3.88m in company stock

nLIGHT CFO Joseph John Corso sold $3.88 million of stock across May 19-20, including a tax-withholding sale and 10b5-1 plan transactions, with shares now at $76.43 after a 437% one-year surge. The company also posted strong Q1 2026 results, with EPS of $0.20 versus $0.09 expected and revenue of $80.2 million versus $72.14 million expected, driven by 55% year-over-year growth and strength in aerospace and defense. Needham raised its target to $80 from $70 and Stifel to $85 from $75, reinforcing a constructive outlook.

Analysis

The market is rewarding a very specific narrative: secular defense exposure plus visible operating leverage. What matters now is not the headline earnings beat, but whether the revenue mix shift toward aerospace/defense compresses the market’s prior “industrial photonics” discount and re-rates LASR closer to a defense-electronics multiple. If that happens, the stock can keep drifting higher even if near-term estimates only inch up, because the valuation anchor is changing faster than consensus EPS.

The insider selling is not a fundamental negative by itself, but it does matter at the margin because it creates a supply overhang exactly when the stock has entered a momentum phase. After a >400% move, incremental buyers are increasingly trend-followers and factor allocators, which makes the name vulnerable to sharp air pockets if growth expectations miss by even a little. The more important second-order risk is that customers and competitors now have proof of strong demand, which typically pulls forward capacity additions and pricing pressure in the supply chain over the next 2-4 quarters.

The consensus likely underestimates how fragile the current setup is if defense order cadence normalizes. A 55% top-line growth rate is impressive, but when a smaller-cap hardware name rerates this fast, the market starts capitalizing peak growth rather than durable growth; that is where disappointment risk rises. The stock can still work for months, but the asymmetry is getting worse: upside depends on continued beats and raised guidance, while downside can be triggered by merely “good” results.

Contrarianly, the stock may be less overvalued on near-term numbers than on normalized margins and cycle timing. If management can translate defense strength into backlog visibility and longer-duration contracts, the current multiple could be justified; if not, the move has probably already priced in the easy part. In short, this is still a momentum winner, but it is transitioning from fundamentals-led upside to expectation-management risk.

Key Decisions for Investors

• Stay tactically long LASR for 2-6 weeks, but use tight risk controls: the stock can continue to rerate on estimate revisions; keep position size modest because post-earnings momentum names often retrace 10-15% on any pause.
• For longer-duration exposure, buy a call spread in LASR (e.g., 1-3 month tenor, 10-15% OTM) rather than outright stock; this captures further multiple expansion while defining downside if the growth narrative cools.
• Pair trade: long defense growth basket / short a weaker industrial-photonics peer over 1-2 quarters; LASR’s defense mix should outperform less levered names if budget-driven demand persists, but the short leg should be selected for valuation and slower order growth.
• If LASR gaps higher on no new fundamental news, take partial profits into strength and reload only after a 1-2 week consolidation; after a 4x+ move, incremental upside is often better bought on pullbacks than chased.
• Watch for any sign of order timing slippage or guidance conservatism in the next print; if that happens, consider a short-term short via puts because the stock’s elevated multiple leaves little margin for error.